A framework for assessing the lifetime economic burden of congenital cytomegalovirus in the United States

• Published in: Cost effectiveness and resource allocation Vol. 17; no. 1; p. 21
• Main Authors: Lucas, Aaron, Sinha, Anushua, Fowler, Karen B, Mladsi, Deirdre, Barnett, Christine, Samant, Salome, Gibson, Laura
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 03.10.2019; BioMed Central; BMC
• Subjects: Analysis; Burden of illness; Care and treatment; Caregivers; cCMV; Child development; Congenital; Congenital diseases; Cost analysis; Cost estimates; Costs; Cytomegalovirus; Cytomegalovirus infections; Disability; Economic; Economic aspects; FDA approval; Fetuses; Framework; Health care costs; Health care expenditures; Infections; Literature reviews; Patients; Pediatrics; Perinatal infection; Prevention; Vaccines; United States; United States > US; Cytomegalovirus; Burden of illness; Economic; Congenital; cCMV; Cost; Framework

In the United States (US), congenital cytomegalovirus infection (cCMVi) is a major cause of permanent disabilities and the most common etiology of non-genetic sensorineural hearing loss. Evaluations of prevention strategies will require estimates of the economic implications of cCMVi. We aimed to de...